Global Basic Infusion Market Research Report 2023

Publisher Name :
Date: 03-Feb-2023
No. of pages: 108
Inquire Before Buying

Highlights

The global Basic Infusion market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

North American market for Basic Infusion is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Basic Infusion is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of Basic Infusion include Baxter, B. Braun, Fresenius Kabi, Kelun Pharma, Otsuka Pharmaceutical, JW Pharmaceutical, Pfizer, Teva Pharmaceutical and Haisco Pharmaceutical Group, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Basic Infusion, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Basic Infusion.

The Basic Infusion market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Basic Infusion market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Basic Infusion manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

By Company

- Baxter

- B. Braun

- Fresenius Kabi

- Kelun Pharma

- Otsuka Pharmaceutical

- JW Pharmaceutical

- Pfizer

- Teva Pharmaceutical

- Haisco Pharmaceutical Group

- King York

- Cisen

- Lummy

- Grand Life Sciences

- Medisan

- BBCA Pharmaceutical

- Biokin Pharmaceutical

- Xi'an Libang Pharmaceutical

- Lionco Pharmaceutical

- China Meheco Kangli

Segment by Type

- Glucose

- Sodium Chloride

- Compound Product

Segment by Application

- max. 100ml

- 250ml

- 500ml

- min. 1L

Consumption by Region

- North America

- United States

- Canada

- Europe

- Germany

- France

- U.K.

- Italy

- Russia

- Asia-Pacific

- China

- Japan

- South Korea

- India

- Australia

- China Taiwan

- Indonesia

- Thailand

- Malaysia

- Latin America

- Mexico

- Brazil

- Argentina

- Middle East & Africa

- Turkey

- Saudi Arabia

- UAE

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Basic Infusion manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Basic Infusion in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

Global Basic Infusion Market Research Report 2023

Table of Contents
1 Basic Infusion Market Overview
1.1 Product Overview and Scope of Basic Infusion
1.2 Basic Infusion Segment by Type
1.2.1 Global Basic Infusion Market Value Comparison by Type (2023-2029)
1.2.2 Glucose
1.2.3 Sodium Chloride
1.2.4 Compound Product
1.3 Basic Infusion Segment by Application
1.3.1 Global Basic Infusion Market Value by Application: (2023-2029)
1.3.2 max. 100ml
1.3.3 250ml
1.3.4 500ml
1.3.5 min. 1L
1.4 Global Basic Infusion Market Size Estimates and Forecasts
1.4.1 Global Basic Infusion Revenue 2018-2029
1.4.2 Global Basic Infusion Sales 2018-2029
1.4.3 Global Basic Infusion Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Basic Infusion Market Competition by Manufacturers
2.1 Global Basic Infusion Sales Market Share by Manufacturers (2018-2023)
2.2 Global Basic Infusion Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Basic Infusion Average Price by Manufacturers (2018-2023)
2.4 Global Basic Infusion Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Basic Infusion, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Basic Infusion, Product Type & Application
2.7 Basic Infusion Market Competitive Situation and Trends
2.7.1 Basic Infusion Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Basic Infusion Players Market Share by Revenue
2.7.3 Global Basic Infusion Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Basic Infusion Retrospective Market Scenario by Region
3.1 Global Basic Infusion Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Basic Infusion Global Basic Infusion Sales by Region: 2018-2029
3.2.1 Global Basic Infusion Sales by Region: 2018-2023
3.2.2 Global Basic Infusion Sales by Region: 2024-2029
3.3 Global Basic Infusion Global Basic Infusion Revenue by Region: 2018-2029
3.3.1 Global Basic Infusion Revenue by Region: 2018-2023
3.3.2 Global Basic Infusion Revenue by Region: 2024-2029
3.4 North America Basic Infusion Market Facts & Figures by Country
3.4.1 North America Basic Infusion Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Basic Infusion Sales by Country (2018-2029)
3.4.3 North America Basic Infusion Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Basic Infusion Market Facts & Figures by Country
3.5.1 Europe Basic Infusion Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Basic Infusion Sales by Country (2018-2029)
3.5.3 Europe Basic Infusion Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Basic Infusion Market Facts & Figures by Country
3.6.1 Asia Pacific Basic Infusion Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Basic Infusion Sales by Country (2018-2029)
3.6.3 Asia Pacific Basic Infusion Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Basic Infusion Market Facts & Figures by Country
3.7.1 Latin America Basic Infusion Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Basic Infusion Sales by Country (2018-2029)
3.7.3 Latin America Basic Infusion Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Basic Infusion Market Facts & Figures by Country
3.8.1 Middle East and Africa Basic Infusion Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Basic Infusion Sales by Country (2018-2029)
3.8.3 Middle East and Africa Basic Infusion Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Basic Infusion Sales by Type (2018-2029)
4.1.1 Global Basic Infusion Sales by Type (2018-2023)
4.1.2 Global Basic Infusion Sales by Type (2024-2029)
4.1.3 Global Basic Infusion Sales Market Share by Type (2018-2029)
4.2 Global Basic Infusion Revenue by Type (2018-2029)
4.2.1 Global Basic Infusion Revenue by Type (2018-2023)
4.2.2 Global Basic Infusion Revenue by Type (2024-2029)
4.2.3 Global Basic Infusion Revenue Market Share by Type (2018-2029)
4.3 Global Basic Infusion Price by Type (2018-2029)
5 Segment by Application
5.1 Global Basic Infusion Sales by Application (2018-2029)
5.1.1 Global Basic Infusion Sales by Application (2018-2023)
5.1.2 Global Basic Infusion Sales by Application (2024-2029)
5.1.3 Global Basic Infusion Sales Market Share by Application (2018-2029)
5.2 Global Basic Infusion Revenue by Application (2018-2029)
5.2.1 Global Basic Infusion Revenue by Application (2018-2023)
5.2.2 Global Basic Infusion Revenue by Application (2024-2029)
5.2.3 Global Basic Infusion Revenue Market Share by Application (2018-2029)
5.3 Global Basic Infusion Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Corporation Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Basic Infusion Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Baxter Basic Infusion Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 B. Braun
6.2.1 B. Braun Corporation Information
6.2.2 B. Braun Description and Business Overview
6.2.3 B. Braun Basic Infusion Sales, Revenue and Gross Margin (2018-2023)
6.2.4 B. Braun Basic Infusion Product Portfolio
6.2.5 B. Braun Recent Developments/Updates
6.3 Fresenius Kabi
6.3.1 Fresenius Kabi Corporation Information
6.3.2 Fresenius Kabi Description and Business Overview
6.3.3 Fresenius Kabi Basic Infusion Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Fresenius Kabi Basic Infusion Product Portfolio
6.3.5 Fresenius Kabi Recent Developments/Updates
6.4 Kelun Pharma
6.4.1 Kelun Pharma Corporation Information
6.4.2 Kelun Pharma Description and Business Overview
6.4.3 Kelun Pharma Basic Infusion Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Kelun Pharma Basic Infusion Product Portfolio
6.4.5 Kelun Pharma Recent Developments/Updates
6.5 Otsuka Pharmaceutical
6.5.1 Otsuka Pharmaceutical Corporation Information
6.5.2 Otsuka Pharmaceutical Description and Business Overview
6.5.3 Otsuka Pharmaceutical Basic Infusion Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Otsuka Pharmaceutical Basic Infusion Product Portfolio
6.5.5 Otsuka Pharmaceutical Recent Developments/Updates
6.6 JW Pharmaceutical
6.6.1 JW Pharmaceutical Corporation Information
6.6.2 JW Pharmaceutical Description and Business Overview
6.6.3 JW Pharmaceutical Basic Infusion Sales, Revenue and Gross Margin (2018-2023)
6.6.4 JW Pharmaceutical Basic Infusion Product Portfolio
6.6.5 JW Pharmaceutical Recent Developments/Updates
6.7 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Basic Infusion Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Pfizer Basic Infusion Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 Teva Pharmaceutical
6.8.1 Teva Pharmaceutical Corporation Information
6.8.2 Teva Pharmaceutical Description and Business Overview
6.8.3 Teva Pharmaceutical Basic Infusion Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Teva Pharmaceutical Basic Infusion Product Portfolio
6.8.5 Teva Pharmaceutical Recent Developments/Updates
6.9 Haisco Pharmaceutical Group
6.9.1 Haisco Pharmaceutical Group Corporation Information
6.9.2 Haisco Pharmaceutical Group Description and Business Overview
6.9.3 Haisco Pharmaceutical Group Basic Infusion Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Haisco Pharmaceutical Group Basic Infusion Product Portfolio
6.9.5 Haisco Pharmaceutical Group Recent Developments/Updates
6.10 King York
6.10.1 King York Corporation Information
6.10.2 King York Description and Business Overview
6.10.3 King York Basic Infusion Sales, Revenue and Gross Margin (2018-2023)
6.10.4 King York Basic Infusion Product Portfolio
6.10.5 King York Recent Developments/Updates
6.11 Cisen
6.11.1 Cisen Corporation Information
6.11.2 Cisen Basic Infusion Description and Business Overview
6.11.3 Cisen Basic Infusion Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Cisen Basic Infusion Product Portfolio
6.11.5 Cisen Recent Developments/Updates
6.12 Lummy
6.12.1 Lummy Corporation Information
6.12.2 Lummy Basic Infusion Description and Business Overview
6.12.3 Lummy Basic Infusion Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Lummy Basic Infusion Product Portfolio
6.12.5 Lummy Recent Developments/Updates
6.13 Grand Life Sciences
6.13.1 Grand Life Sciences Corporation Information
6.13.2 Grand Life Sciences Basic Infusion Description and Business Overview
6.13.3 Grand Life Sciences Basic Infusion Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Grand Life Sciences Basic Infusion Product Portfolio
6.13.5 Grand Life Sciences Recent Developments/Updates
6.14 Medisan
6.14.1 Medisan Corporation Information
6.14.2 Medisan Basic Infusion Description and Business Overview
6.14.3 Medisan Basic Infusion Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Medisan Basic Infusion Product Portfolio
6.14.5 Medisan Recent Developments/Updates
6.15 BBCA Pharmaceutical
6.15.1 BBCA Pharmaceutical Corporation Information
6.15.2 BBCA Pharmaceutical Basic Infusion Description and Business Overview
6.15.3 BBCA Pharmaceutical Basic Infusion Sales, Revenue and Gross Margin (2018-2023)
6.15.4 BBCA Pharmaceutical Basic Infusion Product Portfolio
6.15.5 BBCA Pharmaceutical Recent Developments/Updates
6.16 Biokin Pharmaceutical
6.16.1 Biokin Pharmaceutical Corporation Information
6.16.2 Biokin Pharmaceutical Basic Infusion Description and Business Overview
6.16.3 Biokin Pharmaceutical Basic Infusion Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Biokin Pharmaceutical Basic Infusion Product Portfolio
6.16.5 Biokin Pharmaceutical Recent Developments/Updates
6.17 Xi'an Libang Pharmaceutical
6.17.1 Xi'an Libang Pharmaceutical Corporation Information
6.17.2 Xi'an Libang Pharmaceutical Basic Infusion Description and Business Overview
6.17.3 Xi'an Libang Pharmaceutical Basic Infusion Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Xi'an Libang Pharmaceutical Basic Infusion Product Portfolio
6.17.5 Xi'an Libang Pharmaceutical Recent Developments/Updates
6.18 Lionco Pharmaceutical
6.18.1 Lionco Pharmaceutical Corporation Information
6.18.2 Lionco Pharmaceutical Basic Infusion Description and Business Overview
6.18.3 Lionco Pharmaceutical Basic Infusion Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Lionco Pharmaceutical Basic Infusion Product Portfolio
6.18.5 Lionco Pharmaceutical Recent Developments/Updates
6.19 China Meheco Kangli
6.19.1 China Meheco Kangli Corporation Information
6.19.2 China Meheco Kangli Basic Infusion Description and Business Overview
6.19.3 China Meheco Kangli Basic Infusion Sales, Revenue and Gross Margin (2018-2023)
6.19.4 China Meheco Kangli Basic Infusion Product Portfolio
6.19.5 China Meheco Kangli Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Basic Infusion Industry Chain Analysis
7.2 Basic Infusion Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Basic Infusion Production Mode & Process
7.4 Basic Infusion Sales and Marketing
7.4.1 Basic Infusion Sales Channels
7.4.2 Basic Infusion Distributors
7.5 Basic Infusion Customers
8 Basic Infusion Market Dynamics
8.1 Basic Infusion Industry Trends
8.2 Basic Infusion Market Drivers
8.3 Basic Infusion Market Challenges
8.4 Basic Infusion Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Basic Infusion Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Basic Infusion Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Basic Infusion Market Competitive Situation by Manufacturers in 2022
Table 4. Global Basic Infusion Sales (Tons) of Key Manufacturers (2018-2023)
Table 5. Global Basic Infusion Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Basic Infusion Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Basic Infusion Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Basic Infusion Average Price (US$/Ton) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Basic Infusion, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Basic Infusion, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Basic Infusion, Product Type & Application
Table 12. Global Key Manufacturers of Basic Infusion, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Basic Infusion by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Basic Infusion as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Basic Infusion Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Basic Infusion Sales by Region (2018-2023) & (Tons)
Table 18. Global Basic Infusion Sales Market Share by Region (2018-2023)
Table 19. Global Basic Infusion Sales by Region (2024-2029) & (Tons)
Table 20. Global Basic Infusion Sales Market Share by Region (2024-2029)
Table 21. Global Basic Infusion Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Basic Infusion Revenue Market Share by Region (2018-2023)
Table 23. Global Basic Infusion Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Basic Infusion Revenue Market Share by Region (2024-2029)
Table 25. North America Basic Infusion Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Basic Infusion Sales by Country (2018-2023) & (Tons)
Table 27. North America Basic Infusion Sales by Country (2024-2029) & (Tons)
Table 28. North America Basic Infusion Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Basic Infusion Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Basic Infusion Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Basic Infusion Sales by Country (2018-2023) & (Tons)
Table 32. Europe Basic Infusion Sales by Country (2024-2029) & (Tons)
Table 33. Europe Basic Infusion Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Basic Infusion Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Basic Infusion Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Basic Infusion Sales by Region (2018-2023) & (Tons)
Table 37. Asia Pacific Basic Infusion Sales by Region (2024-2029) & (Tons)
Table 38. Asia Pacific Basic Infusion Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Basic Infusion Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Basic Infusion Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Basic Infusion Sales by Country (2018-2023) & (Tons)
Table 42. Latin America Basic Infusion Sales by Country (2024-2029) & (Tons)
Table 43. Latin America Basic Infusion Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Basic Infusion Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Basic Infusion Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Basic Infusion Sales by Country (2018-2023) & (Tons)
Table 47. Middle East & Africa Basic Infusion Sales by Country (2024-2029) & (Tons)
Table 48. Middle East & Africa Basic Infusion Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Basic Infusion Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Basic Infusion Sales (Tons) by Type (2018-2023)
Table 51. Global Basic Infusion Sales (Tons) by Type (2024-2029)
Table 52. Global Basic Infusion Sales Market Share by Type (2018-2023)
Table 53. Global Basic Infusion Sales Market Share by Type (2024-2029)
Table 54. Global Basic Infusion Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Basic Infusion Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Basic Infusion Revenue Market Share by Type (2018-2023)
Table 57. Global Basic Infusion Revenue Market Share by Type (2024-2029)
Table 58. Global Basic Infusion Price (US$/Ton) by Type (2018-2023)
Table 59. Global Basic Infusion Price (US$/Ton) by Type (2024-2029)
Table 60. Global Basic Infusion Sales (Tons) by Application (2018-2023)
Table 61. Global Basic Infusion Sales (Tons) by Application (2024-2029)
Table 62. Global Basic Infusion Sales Market Share by Application (2018-2023)
Table 63. Global Basic Infusion Sales Market Share by Application (2024-2029)
Table 64. Global Basic Infusion Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Basic Infusion Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Basic Infusion Revenue Market Share by Application (2018-2023)
Table 67. Global Basic Infusion Revenue Market Share by Application (2024-2029)
Table 68. Global Basic Infusion Price (US$/Ton) by Application (2018-2023)
Table 69. Global Basic Infusion Price (US$/Ton) by Application (2024-2029)
Table 70. Baxter Corporation Information
Table 71. Baxter Description and Business Overview
Table 72. Baxter Basic Infusion Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 73. Baxter Basic Infusion Product
Table 74. Baxter Recent Developments/Updates
Table 75. B. Braun Corporation Information
Table 76. B. Braun Description and Business Overview
Table 77. B. Braun Basic Infusion Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 78. B. Braun Basic Infusion Product
Table 79. B. Braun Recent Developments/Updates
Table 80. Fresenius Kabi Corporation Information
Table 81. Fresenius Kabi Description and Business Overview
Table 82. Fresenius Kabi Basic Infusion Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 83. Fresenius Kabi Basic Infusion Product
Table 84. Fresenius Kabi Recent Developments/Updates
Table 85. Kelun Pharma Corporation Information
Table 86. Kelun Pharma Description and Business Overview
Table 87. Kelun Pharma Basic Infusion Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 88. Kelun Pharma Basic Infusion Product
Table 89. Kelun Pharma Recent Developments/Updates
Table 90. Otsuka Pharmaceutical Corporation Information
Table 91. Otsuka Pharmaceutical Description and Business Overview
Table 92. Otsuka Pharmaceutical Basic Infusion Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 93. Otsuka Pharmaceutical Basic Infusion Product
Table 94. Otsuka Pharmaceutical Recent Developments/Updates
Table 95. JW Pharmaceutical Corporation Information
Table 96. JW Pharmaceutical Description and Business Overview
Table 97. JW Pharmaceutical Basic Infusion Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 98. JW Pharmaceutical Basic Infusion Product
Table 99. JW Pharmaceutical Recent Developments/Updates
Table 100. Pfizer Corporation Information
Table 101. Pfizer Description and Business Overview
Table 102. Pfizer Basic Infusion Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 103. Pfizer Basic Infusion Product
Table 104. Pfizer Recent Developments/Updates
Table 105. Teva Pharmaceutical Corporation Information
Table 106. Teva Pharmaceutical Description and Business Overview
Table 107. Teva Pharmaceutical Basic Infusion Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 108. Teva Pharmaceutical Basic Infusion Product
Table 109. Teva Pharmaceutical Recent Developments/Updates
Table 110. Haisco Pharmaceutical Group Corporation Information
Table 111. Haisco Pharmaceutical Group Description and Business Overview
Table 112. Haisco Pharmaceutical Group Basic Infusion Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 113. Haisco Pharmaceutical Group Basic Infusion Product
Table 114. Haisco Pharmaceutical Group Recent Developments/Updates
Table 115. King York Corporation Information
Table 116. King York Description and Business Overview
Table 117. King York Basic Infusion Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 118. King York Basic Infusion Product
Table 119. King York Recent Developments/Updates
Table 120. Cisen Corporation Information
Table 121. Cisen Description and Business Overview
Table 122. Cisen Basic Infusion Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 123. Cisen Basic Infusion Product
Table 124. Cisen Recent Developments/Updates
Table 125. Lummy Corporation Information
Table 126. Lummy Description and Business Overview
Table 127. Lummy Basic Infusion Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 128. Lummy Basic Infusion Product
Table 129. Lummy Recent Developments/Updates
Table 130. Grand Life Sciences Corporation Information
Table 131. Grand Life Sciences Description and Business Overview
Table 132. Grand Life Sciences Basic Infusion Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 133. Grand Life Sciences Basic Infusion Product
Table 134. Grand Life Sciences Recent Developments/Updates
Table 135. Medisan Corporation Information
Table 136. Medisan Description and Business Overview
Table 137. Medisan Basic Infusion Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 138. Medisan Basic Infusion Product
Table 139. Medisan Recent Developments/Updates
Table 140. BBCA Pharmaceutical Corporation Information
Table 141. BBCA Pharmaceutical Description and Business Overview
Table 142. BBCA Pharmaceutical Basic Infusion Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 143. BBCA Pharmaceutical Basic Infusion Product
Table 144. BBCA Pharmaceutical Recent Developments/Updates
Table 145. Biokin Pharmaceutical Corporation Information
Table 146. Biokin Pharmaceutical Description and Business Overview
Table 147. Biokin Pharmaceutical Basic Infusion Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 148. Biokin Pharmaceutical Basic Infusion Product
Table 149. Biokin Pharmaceutical Recent Developments/Updates
Table 150. Xi'an Libang Pharmaceutical Corporation Information
Table 151. Xi'an Libang Pharmaceutical Description and Business Overview
Table 152. Xi'an Libang Pharmaceutical Basic Infusion Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 153. Xi'an Libang Pharmaceutical Basic Infusion Product
Table 154. Xi'an Libang Pharmaceutical Recent Developments/Updates
Table 155. Lionco Pharmaceutical Corporation Information
Table 156. Lionco Pharmaceutical Description and Business Overview
Table 157. Lionco Pharmaceutical Basic Infusion Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 158. Lionco Pharmaceutical Basic Infusion Product
Table 159. Lionco Pharmaceutical Recent Developments/Updates
Table 160. China Meheco Kangli Corporation Information
Table 161. China Meheco Kangli Description and Business Overview
Table 162. China Meheco Kangli Basic Infusion Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 163. China Meheco Kangli Basic Infusion Product
Table 164. China Meheco Kangli Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Basic Infusion Distributors List
Table 168. Basic Infusion Customers List
Table 169. Basic Infusion Market Trends
Table 170. Basic Infusion Market Drivers
Table 171. Basic Infusion Market Challenges
Table 172. Basic Infusion Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Basic Infusion
Figure 2. Global Basic Infusion Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Basic Infusion Market Share by Type in 2022 & 2029
Figure 4. Glucose Product Picture
Figure 5. Sodium Chloride Product Picture
Figure 6. Compound Product Product Picture
Figure 7. Global Basic Infusion Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Basic Infusion Market Share by Application in 2022 & 2029
Figure 9. max. 100ml
Figure 10. 250ml
Figure 11. 500ml
Figure 12. min. 1L
Figure 13. Global Basic Infusion Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Basic Infusion Market Size (2018-2029) & (US$ Million)
Figure 15. Global Basic Infusion Sales (2018-2029) & (Tons)
Figure 16. Global Basic Infusion Average Price (US$/Ton) & (2018-2029)
Figure 17. Basic Infusion Report Years Considered
Figure 18. Basic Infusion Sales Share by Manufacturers in 2022
Figure 19. Global Basic Infusion Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Basic Infusion Players: Market Share by Revenue in 2022
Figure 21. Basic Infusion Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Basic Infusion Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. North America Basic Infusion Sales Market Share by Country (2018-2029)
Figure 24. North America Basic Infusion Revenue Market Share by Country (2018-2029)
Figure 25. United States Basic Infusion Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Basic Infusion Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Basic Infusion Sales Market Share by Country (2018-2029)
Figure 28. Europe Basic Infusion Revenue Market Share by Country (2018-2029)
Figure 29. Germany Basic Infusion Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Basic Infusion Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. Basic Infusion Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Basic Infusion Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Basic Infusion Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Basic Infusion Sales Market Share by Region (2018-2029)
Figure 35. Asia Pacific Basic Infusion Revenue Market Share by Region (2018-2029)
Figure 36. China Basic Infusion Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Japan Basic Infusion Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. South Korea Basic Infusion Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. India Basic Infusion Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Australia Basic Infusion Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. China Taiwan Basic Infusion Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Indonesia Basic Infusion Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Thailand Basic Infusion Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Malaysia Basic Infusion Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Latin America Basic Infusion Sales Market Share by Country (2018-2029)
Figure 46. Latin America Basic Infusion Revenue Market Share by Country (2018-2029)
Figure 47. Mexico Basic Infusion Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Brazil Basic Infusion Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Argentina Basic Infusion Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Basic Infusion Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa Basic Infusion Revenue Market Share by Country (2018-2029)
Figure 52. Turkey Basic Infusion Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Basic Infusion Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. UAE Basic Infusion Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of Basic Infusion by Type (2018-2029)
Figure 56. Global Revenue Market Share of Basic Infusion by Type (2018-2029)
Figure 57. Global Basic Infusion Price (US$/Ton) by Type (2018-2029)
Figure 58. Global Sales Market Share of Basic Infusion by Application (2018-2029)
Figure 59. Global Revenue Market Share of Basic Infusion by Application (2018-2029)
Figure 60. Global Basic Infusion Price (US$/Ton) by Application (2018-2029)
Figure 61. Basic Infusion Value Chain
Figure 62. Basic Infusion Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs